BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $256,000 | +6.2% | 2,970 | 0.0% | 0.03% | -14.3% |
| Q1 2020 | $241,000 | -96.6% | 2,970 | -96.5% | 0.04% | -95.5% |
| Q4 2019 | $7,158,000 | -13.1% | 85,606 | -9.1% | 0.78% | -18.9% |
| Q3 2019 | $8,236,000 | +10.0% | 94,164 | +3.0% | 0.96% | +1.6% |
| Q2 2019 | $7,490,000 | -30.2% | 91,454 | -30.7% | 0.94% | -31.2% |
| Q1 2019 | $10,735,000 | +32.7% | 132,031 | +7.4% | 1.37% | +9.3% |
| Q4 2018 | $8,089,000 | -5.8% | 122,896 | +10.3% | 1.25% | +8.7% |
| Q3 2018 | $8,586,000 | +13.7% | 111,373 | +8.9% | 1.15% | +1.2% |
| Q2 2018 | $7,554,000 | +11.8% | 102,297 | -1.5% | 1.14% | +6.0% |
| Q1 2018 | $6,754,000 | +9.0% | 103,844 | +8.4% | 1.08% | +12.1% |
| Q4 2017 | $6,194,000 | +1.5% | 95,819 | -1.4% | 0.96% | +0.5% |
| Q3 2017 | $6,100,000 | +119.5% | 97,206 | +111.7% | 0.95% | +14.7% |
| Q2 2017 | $2,779,000 | -99.9% | 45,911 | +21.5% | 0.83% | +30.4% |
| Q1 2017 | $1,960,256,000 | +127854.0% | 37,799 | +9.4% | 0.64% | +14.5% |
| Q4 2016 | $1,532,000 | – | 34,542 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |